ÍøºìºÚÁÏ

Skip to main content
(352) 733-0111

John A Ligon, MD : Research

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of John A Ligon
(352) 733-0111 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Neoplasms , 4 publications
  • Cell Line, Tumor , 2 publications
  • Bone Neoplasms , 2 publications
  • Immunocompromised Host , 2 publications

Research activity

38 publications

454 citations

Why is this important?

Active clinical trials

OMS721-HCT-002

The purpose of this study is to evaluate the safety and efficacy of narsoplimab in pediatric patients with thrombotic microangiopathies (TMA) following hematopoietic stem cell transplant (HSCT).

Investigator
John A Ligon
Status
Accepting Candidates
Ages
28 Days - 17 Years
Sexes
All

My publications

38 publications

2022

Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy

Blood Advances

•

2022

Fertility and CAR T-cells: Current practice and future directions

Transplantation and Cellular Therapy

•

2022

Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical Trials.

The oncologist

•

2022

Sampling Multiple Catheter Lumens to Improve Detection of Bloodstream Infection in Pediatric Oncology Patients.

Journal of pediatric hematology/oncology

•

2022

The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes

Blood Advances

•